A new global survey of patient and urologist perception and experience—conducted in collaboration with leading bladder cancer professional and patient organizations—reveals the physical, mental, and ...

AstraZeneca’s first foray with PD-L1 inhibitor Imfinzi as a treatment for bladder cancer was a flop. | Following an FDA ...

Bladder cancer has been billed by AstraZeneca as a key growth area for its immunotherapy Imfinzi, an ambition that has now ...

May 14 (Reuters) - AstraZeneca said on Thursday that a late-stage trial of Imfinzi, combined with a targeted therapy prior to ...

Newswatch 16's Emily Kress spoke with a physician assistant at UPMC about how Botox can help treat an overactive bladder in ...

Urologic Health Inc., a medical device company pioneering non-invasive urodynamics, today announced the successful closing of an $11 million seed financing round led by an undisclosed strategic ...

UAB delivers its first implantable tibial neuromodulation therapy for urge urinary incontinence, expanding durable, minimally ...

AstraZeneca PLC AZN on Thursday said interim results from the Phase 3 VOLGA trial showed that perioperative treatment with ...

“There’s almost this disbelief that washes over you, like your brain can’t fully process what it’s being told," James “Jimi” ...

But when Jimi began experiencing bladder cancer symptoms, including blood in his urine, he felt a different kind of rush. It ...

An innovative treatment for bladder cancer successfully prevented the recurrence of tumors and improved survival rates following surgery.